Behrad Derakhshan

Behrad Derakhshan, PhD, currently serves as Chief Business Officer at Edgewise Therapeutics and Board Member at Innoskel. Previously, Derakhshan held significant roles including Chief Business Officer at VectivBio, Vice President and Head of Business Development at Therachon, and Director of Business Development at Alexion Pharmaceuticals, Inc. Other past positions include Associate Director at Navigant Consulting Inc., Senior Consultant at Easton Associates, and Postdoctoral Associate at both Yale School of Medicine and Weill Cornell Medical College. Derakhshan's educational background includes a PhD in Pharmacology/Biochemistry from Weill Cornell Medical College/University of Surrey, a postdoctoral fellowship in Proteomics/Cardiovascular Biology from Yale University School of Medicine, and a B.Sc. in Biochemistry from the University of Surrey.